Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Janus

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|November 23, 2011
[Renal insufficiency and breast cancer]Philippe Beuzeboc, Christophe Le Tourneau, Joseph Gligorov, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2013
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC surveyNicolas Janus, Florian Scotte, Jean-Baptiste Rey, et al.
Cancer|July 20, 2007
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) studyVincent Launay-Vacher, Stéphane Oudard, Nicolas Janus, et al.
Cancer|April 17, 2014
Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patientsVincent Launay-Vacher, Sarah Zimner-Rapuch, Nicolas Poulalhon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY studySvetlana Karie-Guigues, Nicolas Janus, Faouzi Saliba, et al.
Critical Reviews in Oncology/Hematology|November 8, 2008
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA studyVincent Launay-Vacher, Jean-Philippe Spano, Nicolas Janus, et al.
Clinical Genitourinary Cancer|October 10, 2009
Drug management of prostate cancer: prevalence and consequences of renal insufficiencyVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Lung|October 23, 2008
Lung cancer and renal insufficiency: prevalence and anticancer drug issuesVincent Launay-Vacher, Reza Etessami, Nicolas Janus, et al.
Breast Cancer Research and Treatment|August 16, 2008
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issuesVincent Launay-Vacher, Joseph Gligorov, Christophe Le Tourneau, et al.
Investigative Radiology|October 31, 2013
Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique studySabine Amet, Vincent Launay-Vacher, Olivier Clément, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|November 23, 2011
[Renal insufficiency and breast cancer]Philippe Beuzeboc, Christophe Le Tourneau, Joseph Gligorov, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 30, 2013
Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC surveyNicolas Janus, Florian Scotte, Jean-Baptiste Rey, et al.
Cancer|July 20, 2007
Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) studyVincent Launay-Vacher, Stéphane Oudard, Nicolas Janus, et al.
Cancer|April 17, 2014
Acute renal failure associated with the new BRAF inhibitor vemurafenib: a case series of 8 patientsVincent Launay-Vacher, Sarah Zimner-Rapuch, Nicolas Poulalhon, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 2009
Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY studySvetlana Karie-Guigues, Nicolas Janus, Faouzi Saliba, et al.
Critical Reviews in Oncology/Hematology|November 8, 2008
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA studyVincent Launay-Vacher, Jean-Philippe Spano, Nicolas Janus, et al.
Clinical Genitourinary Cancer|October 10, 2009
Drug management of prostate cancer: prevalence and consequences of renal insufficiencyVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Lung|October 23, 2008
Lung cancer and renal insufficiency: prevalence and anticancer drug issuesVincent Launay-Vacher, Reza Etessami, Nicolas Janus, et al.
Breast Cancer Research and Treatment|August 16, 2008
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issuesVincent Launay-Vacher, Joseph Gligorov, Christophe Le Tourneau, et al.
Investigative Radiology|October 31, 2013
Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique studySabine Amet, Vincent Launay-Vacher, Olivier Clément, et al.
Pageof 5